Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46 results about "6-gingerol" patented technology

Gingerol, properly as [6]-gingerol, is a chemical compound found in fresh ginger.Chemically, gingerol is a relative of capsaicin and piperine, the compounds which give chilli peppers and black pepper their respective spiciness. It is normally found as a pungent yellow oil, but also can form a low-melting crystalline solid.

Inhibitors and Enhancers of Uridine Diphosphate-Glucuronosyltransferase 2B (UGT2B)

A UGT2B inhibitor capable of increasing the bio-availability of a drug, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: capillarisin, isorhamnetin, β-naphthoflavone, α-naphthoflavone, hesperetin, terpineol, (+)-limonene, β-myrcene, swertiamarin, eriodictyol, cineole, apigenin, baicalin, ursolic acid, isovitexin, lauryl alcohol, puerarin, trans-cinnamaldehyde, 3-phenylpropyl acetate, isoliquritigenin, paeoniflorin, gallic acid, genistein, glycyrrhizin, protocatechuic acid, ethyl myristate, umbelliferone, PEG (Polyethylene glycol) 400, PEG 2000, PEG 4000, Tween 20, Tween 60, Tween 80, BRIJ® 58, BRIJ® 76, Pluronic® F68, Pluronic® F127, and a combination thereof. A UGT2B enhancer capable of enhancing a clearance rate of morphine-like analgesic agents, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: nordihydroguaiaretic acid, wogonin, trans-cinnamic acid, baicalein, quercetin, daidzein, oleanolic acid, homoorientin, hesperetin, narigin, neohesperidin, (+)-epicatechin, hesperidin, liquiritin, eriodictyol, formononetin, quercitrin, genkwanin, kaempferol, isoquercitrin, (+)-catechin, naringenin, daidzin, (−)-epicatechin, luteolin-7-glucoside, ergosterol, rutin, luteolin, ethyl myristate, apigenin, 3-phenylpropyl acetate, umbelliferone, glycyrrhizin, protocatechuic acid, poncirin, isovitexin, 6-gingerol, cineole, genistein, trans-cinnamaldehyde, and a combination thereof.
Owner:NAT DEFENSE MEDICAL CENT

Method for separating 6-gingerol from ginger

The technological process of separating 6-gingerol from ginger includes the steps of: preparing ginger oleoresin, chromatographic separation with silica gel column, preparing coarse gingerol, liquid phase chromatographic separation, eliminating solvent, preparing pure 6-gingerol product, etc. The present invention has high 6-gingerol purity, simple operation, simple technological process and high separation efficiency.
Owner:北矿检测技术股份有限公司

Cytochrome P450 2C9 inhibitors

This invention is to provide multiple specific inhibitors of cytochrome P450 isozyme CYP2C9. These inhibitors can be derived from any combinations with the following compounds including: Tamarixetin, Formononetin, isoliquritigenin, Phloretin, luteolin, Quercitrin, quercetin, myricetin, Wongonin, Puerarin, Genistein, Nordihydroguaiaretic acid, Narigenin, Capillarisin, Chrysin, Fisefin, eriodictyol, 6-Gingerol, Isorhamneti, isoquercitrin, Morin, (+)-Taxifolin, isovitexin, 3-Phenylpropyl Acetate, Oleanolic acid, ursolic acid, β-Myrcene, cinnamic acid, Luteolin-7-Glucoside, Liquiritin, (+)Limonene, Homoorientin, Swertiamarin, Embelin, Daidzein, Poncirin, (−)-Epicatechin, ergosterol. These natural products can be used to enhance the bioavailability of therapeutic agents (drugs).
Owner:NAT DEFENSE MEDICAL CENT

Method for preparing 6-gingerol and 8-gingerol from ginger and ultrafiltration device thereof

The invention discloses a method for preparing 6-gingerol and 8-gingerol from ginger and an ultrafiltration device thereof and belongs to the technical field of the preparation method of natural active products. The method disclosed by the invention sequentially comprises the steps of treating the raw material of the ginger, mixing the homogenate, removing the impurities to obtain a primary extractive, ultra-filtrating to obtain a primary product, and nano-filtrating to obtain a pure product. The ultrafiltration device comprises at least one shell and a pipe unit communicated with the inner cavity of the shell; a closed tubular ultra-filtration is arranged in the inner cavity of the shell; two pipes communicated with the inner cavity of the ultra-filtration are arranged on the upper end part of the ultra-filtration; and an ultrafiltration membrane capable of allowing materials to be filtered to enter a hollow cavity between the ultra-filtration and the shell from the inner cavity of the ultra-filtration is arranged on the tubular wall of the ultra-filtration. Compared with the prior art, the invention has the substantive characteristics and the remarkable progresses of easily-controlled preparation process, convenient and simple operational process, high production efficiency, suitability for large-scale of factory production and capability of improving the level of the health of people.
Owner:吕维学

Method for separating and purifying 6-gingerol by reduced pressure column chromatography and production method of 6-gingerol

The invention relates to the fields of separation and purification and provides a method for separating and purifying 6-gingerol by reduced pressure column chromatography and a production method of the 6-gingerol. The method for separating and purifying the 6-gingerol by the reduced pressure column chromatography comprises the following steps: performing gradient elution on a raw material containing the 6-gingerol through a first mixed solvent with N-hexane-ethyl acetate as a mobile phase in different proportions to obtain a 6-gingerol crude product; and performing gradient elution on the 6-gingerol crude product in a second reduced pressure column through a second mixed solvent with N-hexane-ethyl acetate as a mobile phase in different proportions to obtain a 6-gingerol purified substance. The method for separating and purifying the 6-gingerol by the reduced pressure column chromatography and the production method of the 6-gingerol, provided by the invention, have the benefits that the 6-gingerol is separated and purified by utilizing a two-step reduced pressure gradient elution method; through the reduced pressure operation, the operation is easier to control, and the elution time is short; meanwhile, the N-hexane-ethyl acetate mixed in different proportions is adopted as the mobile phase, the mobile phase is few in types, the consumption is less, and the recovery is easy.
Owner:INST OF GEOCHEM CHINESE ACADEMY OF SCI

Separation and purification method and production method of 6-gingerol

The invention relates to the field of separation and purification, and provides a separation and purification method and a production method of 6-gingerol. The separation and purification method of the 6-gingerol comprises the following steps of: dissolving a raw material containing the 6-gingerol into a first organic solvent, and then carrying out liquid-liquid extraction separation on the firstorganic solvent in which the raw material containing the 6-gingerol is dissolved by using a second organic solvent which is insoluble in the first organic solvent. The production method of the 6-gingerol comprises an extracting method of the 6-gingerol and the separation and purification method of the 6-gingerol. According to the separation and purification method of the 6-gingerol, provided by the embodiment of the invention, the 6-gingerol can be quickly separated and purified through liquid-liquid extraction, e consumed time is short, the organic solvents can be recycled, a separation and purification process is simple, the required equipment is conventional equipment, the yield is high, and large-batch production is easy. According to the production method of the 6-gingerol, provided by the embodiment of the invention, the 6-gingerol obtained through extraction, separation and purification has the advantages of high content, higher yield, shorter consumed time and less organic solvent consumption.
Owner:INST OF GEOCHEM CHINESE ACADEMY OF SCI

Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2b (UGT2B)

A UGT2B inhibitor capable of increasing the bio-availability of a drug, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: capillarisin, isorhamnetin,β-naphthoflavone, α-naphthoflavone, hesperetin, terpineol, (+)-limonene, β-myrcene, swertiamarin, eriodictyol, cineole, apigenin, baicalin, ursolic acid, isovitexin, lauryl alcohol, puerarin, trans-cinnamaldehyde, 3-phenylpropyl acetate, isoliquritigenin, paeoniflorin, gallic acid, genistein, glycyrrhizin, protocatechuic acid, ethyl myristate, umbelliferone, PEG (Polyethylene glycol) 400, PEG 2000, PEG 4000, Tween 20, Tween 60, Tween 80, BRIJ® 58, BRIJ® 76, Pluronic® F68, Pluronic® F127, and a combination thereof. A UGT2B enhancer capable of enhancing a clearance rate of morphine-like analgesic agents, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: nordihydroguaiaretic acid, wogonin, trans-cinnamic acid, baicalein, quercetin, daidzein, oleanolic acid, homoorientin, hesperetin, narigin, neohesperidin, (+)-epicatechin, hesperidin, liquiritin, eriodictyol, formononetin, quercitrin, genkwanin, kaempferol, isoquercitrin, (+)-catechin, naringenin, daidzin, (−)-epicatechin, luteolin-7-glucoside, ergosterol, rutin, luteolin, ethyl myristate, apigenin, 3-phenylpropyl acetate, umbelliferone, glycyrrhizin, protocatechuic acid, poncirin, isovitexin, 6-gingerol, cineole, genistein, trans-cinnamaldehyde, and a combination thereof.
Owner:NAT DEFENSE MEDICAL CENT

Low side effect pharmaceutical composition containing isoniazid

ActiveUS8304394B2Reduce INH-induced side-effectsEliminate side effectsAntibacterial agentsBiocideDaidzeinDiosmin
The present invention features a novel, low side-effect pharmaceutical compound complex, comprising the pharmaceutically effective dose of isoniazid (INH) and pharmaceutically effective dose of one of the following compounds. Said compound was selected from the following groups of compounds: Nordihydroguaiaretic acid, Trans-Cinnamaldehyde, Daidzein, Isovitexin, Kaempferol, disulfuram, β-Myrcene, Quercetin, (−)-Epigallocatechin-3-gallate, (+)-Limonene, Myricetin, Quercitrin, Luteolin-7-Glucoside, Morin, Neohesperidin, Hesperidin, Capillarisin, (−)-Epigallocatechin, Luteolin, Hyperoside, Ethyl Myristate, Tamarixetin, Phloretin, Baicalein, Rutin, Baicalin, Apigenin, Naringenin, Hesperetin, (+)-Epicatechin, (−)-Epicatechin-3-gallat, Isoliquritigenin, Silybin, Vitexin, Genistein, Isorhamnetin, gallic acid, Diosmin, 6-Gingerol, (+)-Taxifolin, Wongonin, Protocatechuic acid, (+)-Catechin, β-naphthoflavone, Embelin, Trans-Cinnamic acid, (−)-Epicatechin, Phloridzin, Puerarin, Umbelliferone, Brij 58, Brij 76, Brij 35, Tween 20, Tween 80, Tween 40, PEG 2000, PEG 400, Pluornic F68, and PEG 4000. The novel, low side-effect compound complex which contains pharmaceutically effective doses of isoniazid (INH), disulfuram (DSF) and / or a third compound, bis-nitrophenyl phosphate (BNPP) can reduce isoniazid (INH)-induced side effects, e.g. hepatotoxicity, etc.
Owner:INT EDUCATION FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products